714 related articles for article (PubMed ID: 26908667)
1. Waning Tdap Effectiveness in Adolescents.
Klein NP; Bartlett J; Fireman B; Baxter R
Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
[TBL] [Abstract][Full Text] [Related]
2. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
[TBL] [Abstract][Full Text] [Related]
3. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
4. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
[TBL] [Abstract][Full Text] [Related]
5. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
[TBL] [Abstract][Full Text] [Related]
6. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
[TBL] [Abstract][Full Text] [Related]
7. Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic.
Acosta AM; DeBolt C; Tasslimi A; Lewis M; Stewart LK; Misegades LK; Messonnier NE; Clark TA; Martin SW; Patel M
Pediatrics; 2015 Jun; 135(6):981-9. PubMed ID: 25941309
[TBL] [Abstract][Full Text] [Related]
8. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
[TBL] [Abstract][Full Text] [Related]
9. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
Misegades LK; Winter K; Harriman K; Talarico J; Messonnier NE; Clark TA; Martin SW
JAMA; 2012 Nov; 308(20):2126-32. PubMed ID: 23188029
[TBL] [Abstract][Full Text] [Related]
10. Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.
Klein NP; Bartlett J; Fireman B; Aukes L; Buck PO; Krishnarajah G; Baxter R
Vaccine; 2017 Jun; 35(26):3395-3400. PubMed ID: 28506516
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis.
Baxter R; Bartlett J; Fireman B; Lewis E; Klein NP
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557752
[TBL] [Abstract][Full Text] [Related]
12. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(25):468-70. PubMed ID: 22739778
[TBL] [Abstract][Full Text] [Related]
13. Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine.
Terranella A; Rea V; Griffith M; Manning S; Sears S; Farmer A; Martin S; Patel M
Vaccine; 2016 May; 34(22):2496-500. PubMed ID: 27038131
[TBL] [Abstract][Full Text] [Related]
14. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Tdap Vaccination Effectiveness in Adolescents in Integrated Health-Care Systems.
Briere EC; Pondo T; Schmidt M; Skoff T; Shang N; Naleway A; Martin S; Jackson ML
J Adolesc Health; 2018 Jun; 62(6):661-666. PubMed ID: 29551624
[TBL] [Abstract][Full Text] [Related]
16. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
Skoff TH; Blain AE; Watt J; Scherzinger K; McMahon M; Zansky SM; Kudish K; Cieslak PR; Lewis M; Shang N; Martin SW
Clin Infect Dis; 2017 Nov; 65(12):1977-1983. PubMed ID: 29028938
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States.
Havers FP; Cho BH; Walker JW; Hariri S
Vaccine; 2020 Jan; 38(2):380-387. PubMed ID: 31676198
[TBL] [Abstract][Full Text] [Related]
18. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.
Jackson ML; Yu O; Nelson JC; Nordin JD; Tartof SY; Klein NP; Donahue JG; Irving SA; Glanz JM; McNeil MM; Jackson LA
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):921-925. PubMed ID: 29862604
[TBL] [Abstract][Full Text] [Related]
19. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
Gidengil CA; Sandora TJ; Lee GM
Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
